𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effector and suppressor lymphoid cells in tumor-bearing guinea-pigs

✍ Scribed by I. Berczi; A. H. Sehon


Publisher
John Wiley and Sons
Year
1979
Tongue
French
Weight
808 KB
Volume
23
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The immune reaction of guinea‐pigs against their growing tumors was studied. Strain 13 guinea‐pigs were killed 2 weeks after SC implantation of the transplantable methylcholanthrene‐induced sarcoma (MC‐D), when the tumor was 2–3 cm In diameter. Spleen, lymph‐node, bone‐marrow and peripheral blood leukocytes (PBL), and subsets of spleen cells and PBL were mixed with lethal doses (10^5^) of tumor cells and inoculated SC into normal recipients. Spleen, lymph‐node and bone‐marrow cells either enhanced or did not influence tumor growth, while PBL exerted a strong inhibitory effect. Normal spleen and normal PBL did not affect tumor growth. The spleen cells of tumor‐bearing animals were separated on nylon wool columns: the first fraction containing T cells was responsible for tumor enhancement, the second fraction containing predominantly non‐T (Ia^+^) cells inhibited tumor growth. Adherent cells had no effect. Similarly, after removal of T cells from the spleens with a specific rabbit antiserum or of non‐T cells plus a minor portion of T cells with an anti‐la serum (produced in strain 2 guinea‐pigs), the remaining cell population had, respectively, an inhibitory or an enhancing effect on tumor growth. By contrast, removal of either T or la^+^ cells from PBL eliminated their anti‐tumor effect. The major portion of splenic T cells formed EA rosettes. EA rosette‐positive cells were restricted to a minor portion of peripheral T lymphocytes. Thus, splenic and peripheral T cells from tumor‐bearing animals were different both functionally and according to their surface markers. It is hypothesized that Fc^+^ T cells are suppressors which are triggered by immune complexes.


📜 SIMILAR VOLUMES


Effector and enhancing lymphoid cells in
✍ K. C. Wang; I. Berczi; E. G. Hoffmann; A. H. Sehon 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 701 KB

## Abstract The Winn assay was used for the study of effector (tumor‐inhibiting) and enhancing (tumor‐promoting) lymphoid cells in BALB/c mice bearing MOPC‐104E plasmacytomas. Kinetic studies with thymus, lymphnode, spleen and bone‐marrow cells revealed that spleen, lymph node and to a lesser exten

Effector and enhancing lymphoid cells in
✍ K. C. Wang; I. Berczi; A. H. Sehon 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 561 KB

## Abstract Some parameters of the Winn assay for the detection of tumor‐suppressing (“effector”) and tumor‐enhancing lymphoid cells were studied in BALB/c mice. Spleen cells of mice that were preimmunized with mitomycin‐C‐treated MOPC‐104E plasmacytoma cells were inhibitory in this test system for

Development of splenic natural suppresso
✍ Jose L. Subiza; Juan E. Vinuela; Rosa Rodriguez; Juana Gil; M. Angeles Figueredo 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 873 KB

Spleen cells from C57BU6J mice bearing Ehrlich carcinoma growing as a solid tumor show progressive unresponsiveness to concanavalin A (Con A) and lipopolysaccharide (LPS) mitogens. This is accompanied by striking spleen enlargement with marked hematopoietic activity. Lymphoproliferative assays of no

Tumor-specific and forssman antigens of
✍ Charles H. Evans; Sarkis H. Ohanian; Adele M. Cooney 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 French ⚖ 673 KB

## Abstract Cloned tumor‐cell lines were derived from two antigenically distinct ascites variants of diethylnitrosamine‐induced guinea‐pig hepatomas (designated line 1 and line 10). Cell‐surface antigens on the ascites and in vitro‐grown tumor cells were analyzed with immunofluorescence, C1 fixatio

Antigen shedding vs. development of natu
✍ Juan E. Viñuela; Rosa Rodriguez; Juana Gil; Javier Coll; Emilio G. La De Concha; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 645 KB

C57BU6J mice immunized with devitalized Ehrlich tumor (ET) cells produce high serum levels of IgM antibodies to E l cell-surface carbohydrates that are critical in the observed resistance against this tumor. However, this response is not found in El-bearing mice at any stage of tumor development. Si